Antisense Therapeutics Limited

Antisense Therapeutics Limitedverified

ATHJF

Price:

$0.012

Market Cap:

$30.19M

Antisense Therapeutics Limited engages in the research and development of novel antisense pharmaceuticals in Australia. Its product pipeline comprises ATL1102, an antisense inhibitor of CD49d, which is in Phase II clinical trial for the treatment of multiple sclerosis, Duchenne Muscular Dystrophy, asthma, and other inflammatory indications. The company's product pipeline also includes ATL1103, a second generation antisense drug designed to block growth hormone receptor expression thereby reducing levels of the hormone insulin-like growth factor-I in the blood, as well as to treat diseases associated with excessive growth hormone action that has completed Phase II clinical trial. Antisense Th...[Read more]

Industry

Drug Manufacturers - Specialty & Generic

IPO Date

2009-09-08

Stock Exchange

PNK

Ticker

ATHJF

The PE Ratio as of November 2024 (TTM) for Antisense Therapeutics Limited (ATHJF) is -1.20

According to Antisense Therapeutics Limited’s latest financial reports and current stock price. The company's current PE Ratio is -1.20. This represents a change of -57.75% compared to the average of -2.84 of the last 4 quarters.

Antisense Therapeutics Limited (ATHJF) Historical PE Ratio (quarterly & annually)

How has ATHJF PE Ratio performed in the past?

The mean historical PE Ratio of Antisense Therapeutics Limited over the last ten years is -3.09. The current -1.20 PE Ratio has changed 3.78% with respect to the historical average. Over the past ten years (40 quarters), ATHJF's PE Ratio was at its highest in in the June 2015 quarter at 3.10. The PE Ratio was at its lowest in in the September 2021 quarter at -19.08.

Quarterly (TTM)
Annual

Average

-3.09

Median

-4.17

Minimum

-12.56

Maximum

19.27

Antisense Therapeutics Limited (ATHJF) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Antisense Therapeutics Limited PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 125.35%

Maximum Annual PE Ratio = 19.27

Minimum Annual Increase = -415.41%

Minimum Annual PE Ratio = -12.56

Quarterly (TTM)
Annual
YearPE RatioChange
2024-1.33-69.88%
2023-4.41-59.99%
2022-11.02-12.21%
2021-12.56125.35%
2020-5.57-11.64%
2019-6.3160.09%
2018-3.94101.28%
2017-1.96-37.12%
2016-3.11-116.15%
201519.27-415.41%

Antisense Therapeutics Limited (ATHJF) Average PE Ratio

How has ATHJF PE Ratio performed in the past?

The current PE Ratio of Antisense Therapeutics Limited (ATHJF) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-5.59

5-year avg

-6.98

10-year avg

-3.09

Antisense Therapeutics Limited (ATHJF) PE Ratio vs. Peers

How is ATHJF’s PE Ratio compared to its peers?

Antisense Therapeutics Limited’s PE Ratio is less than Amexdrug Corporation (4.30), less than Aion Therapeutic Inc. (-0.51), less than Aspen Pharmacare Holdings Limited (14.48), greater than Alterola Biotech, Inc. (-3.80), greater than The BC Bud Corporation (-2.50), greater than Crescita Therapeutics Inc. (-4.42), less than AusCann Group Holdings Ltd (-0.27), greater than Avicanna Inc. (-3.62), greater than Bionoid Pharma Inc. (-406.16),

Build a custom stock screener for Antisense Therapeutics Limited (ATHJF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Antisense Therapeutics Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Antisense Therapeutics Limited (ATHJF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Antisense Therapeutics Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Antisense Therapeutics Limited's PE Ratio?

How is the PE Ratio calculated for Antisense Therapeutics Limited (ATHJF)?

What is the highest PE Ratio for Antisense Therapeutics Limited (ATHJF)?

What is the 3-year average PE Ratio for Antisense Therapeutics Limited (ATHJF)?

What is the 5-year average PE Ratio for Antisense Therapeutics Limited (ATHJF)?

How does the current PE Ratio for Antisense Therapeutics Limited (ATHJF) compare to its historical average?